Affordable Access

Multimodality treatment of germ cell cancer patients who had progression or relapse after high dose chemotherapy and autologous bone marrow transplantation.

Authors
  • Sarosiek, T
  • Rzepecki, P
  • Langiewicz, P
  • Zolnierek, J
  • Barzal, J
  • Szczylik, C
Type
Published Article
Journal
Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Publication Date
Jan 01, 2007
Volume
12
Issue
3
Pages
335–340
Identifiers
PMID: 17918286
Source
Medline
License
Unknown

Abstract

Our results suggest that GCT patients who have relapsed/ progressed after HDC may benefit from further treatment. Best chances for long term survival have those who experience relapse confined to one metastatic site and receive combined treatment (surgery or radiotherapy plus systemic therapy).

Report this publication

Statistics

Seen <100 times